Jamrex Remedies Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 8 Year, 4 Months
- Last Filing with ROC 31 Mar 2020
- Revenue Growth -98.45%
- Profit Growth -6409.85%
- Ebitda -9617.18%
- Total Assets %
About Jamrex Remedies
Jamrex Remedies Private Limited (JRPL) is a Private Limited Indian Non-Government Company incorporated in India on 10 October 2016 (Eight years and four months 12 days old ). Its registered office is in Coimbatore, Tamil Nadu, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2020. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Mohammad Anzar, Mohammad Moidul, Priya Singh, and One other member serve as directors at the Company.
Company Details
- Location
Coimbatore, Tamil Nadu, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U51909TZ2016PTC028081
- Company No.
028081
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Oct 2016
- Date of AGM
30 Oct 2020
- Date of Balance Sheet
31 Mar 2020
- Listing Status
Unlisted
- ROC Code
Roc Coimbatore
Industry
Who are the key members and board of directors at Jamrex Remedies?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mohammad Anzar  | Director | 10-Oct-2016 | Current |
| Mohammad Moidul | Director | 10-Oct-2016 | Current |
| Priya Singh | Director | 10-Oct-2016 | Current |
| Horairajilani Khan | Director | 10-Oct-2016 | Current |
Financial Performance of Jamrex Remedies.
Jamrex Remedies Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 98.45% decrease. The company also saw a substantial fall in profitability, with a 6409.85% decrease in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss |
| ||||||
| Net Worth | |||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Jamrex Remedies?
In 2020, Jamrex Remedies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Jamrex Biotech Private LimitedHorairajilani Khan is a mutual person
Sidza Healthcare Private LimitedMohammad Anzar is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Jamrex Remedies?
Unlock and access historical data on people associated with Jamrex Remedies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Jamrex Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jamrex Remedies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.